Home › Funds › SILVERARC CAPITAL MANAGEMENT, LLC › GH
SILVERARC CAPITAL MANAGEMENT, LLC position in GH
GUARDANT HEALTH INC · Health Care
SILVERARC CAPITAL MANAGEMENT, LLC reported holding 99,826 shares of GH (GUARDANT HEALTH INC) in its Q2 2026 13F filing — a position valued at US$15.0M, representing 1.75% of its reported portfolio and ranking #18 among its reported holdings. SILVERARC CAPITAL MANAGEMENT, LLC has disclosed GH holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How SILVERARC CAPITAL MANAGEMENT, LLC's GH position evolved
SILVERARC CAPITAL MANAGEMENT, LLC first disclosed a stake in GH in Q4 2025 at 91,914 shares (US$9.4M). The position peaked in Q2 2026 at 99,826 shares, worth US$15.0M. Across 3 filings, SILVERARC CAPITAL MANAGEMENT, LLC increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 99,826 shares valued at US$15.0M — an increase of 1,312 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 91.91K | $9.39M | New |
| Q1 2026 | 98.51K | $9.10M | Add |
| Q2 2026 | 99.83K | $14.98M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GH and 13F data
GH (GUARDANT HEALTH INC) is a Health Care company. 58 other funds we track also report a position in GH — the largest reported positions include Deep Track Capital, LP (US$509.1M), FULLER & THALER ASSET MANAGEMENT, INC. (US$394.4M), EVENTIDE ASSET MANAGEMENT, LLC (US$293.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GH
- Deep Track Capital, LP 3.39M sh · $509.10M · Q2 2026
- FULLER & THALER ASSET MANAGEMENT, INC. 2.63M sh · $394.43M · Q2 2026
- EVENTIDE ASSET MANAGEMENT, LLC 1.96M sh · $293.79M · Q2 2026
- WESTFIELD CAPITAL MANAGEMENT CO LP 1.62M sh · $243.72M · Q2 2026
- TWO SIGMA ADVISERS, LP 2.38M sh · $243.33M · Q4 2025
- DRIEHAUS CAPITAL MANAGEMENT LLC 1.53M sh · $230.14M · Q2 2026
- RTW INVESTMENTS, LP 1.48M sh · $222.20M · Q2 2026
- Hood River Capital Management LLC 1.40M sh · $209.34M · Q2 2026
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 1.31M sh · $196.74M · Q2 2026
- Temasek Holdings (Private) Ltd 1.02M sh · $153.62M · Q2 2026
- SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 967.70K sh · $145.18M · Q2 2026
- CADIAN CAPITAL MANAGEMENT, LP 757.39K sh · $113.63M · Q2 2026
More on SILVERARC CAPITAL MANAGEMENT, LLC
FAQ
How long has SILVERARC CAPITAL MANAGEMENT, LLC held GH?
SILVERARC CAPITAL MANAGEMENT, LLC has disclosed GH holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
What is SILVERARC CAPITAL MANAGEMENT, LLC's current position in GH?
As of Q2 2026, SILVERARC CAPITAL MANAGEMENT, LLC holds 99.83K shares of GH (GUARDANT HEALTH INC), valued at $14.98M, representing 1.75% of its reported portfolio and ranking #18.
Has SILVERARC CAPITAL MANAGEMENT, LLC been buying or selling GH?
In the latest 13F filing (Q2 2026), SILVERARC CAPITAL MANAGEMENT, LLC increased its position in GH. The position peaked in Q2 2026 at 99.83K shares.
Which other funds hold GH?
Other major institutional holders of GH include Deep Track Capital, LP, FULLER & THALER ASSET MANAGEMENT, INC., EVENTIDE ASSET MANAGEMENT, LLC, among 58 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.